Passport Capital, LLC, is an investment advisory firm founded in 2000 and based in San Francisco, California. The firm is duly registered with the Securities and Exchange Commission. The top three holdings of Passport Capital, LLC, according to the firm’s SEC 13F filings for the period ended September 30, 2014, was Yahoo! Inc. (NASDAQ:YHOO), CF Industries Holdings, Inc. (NYSE:CF), and Vipshop Holdings Ltd – ADR (NYSE:VIPS).
Yahoo! Inc. (NASDAQ:YHOO) emerged top of the investment list of Passport Capital, LLC, with investment worth $304.85 million. Yahoo! Inc. (NASDAQ:YHOO) is a multinational internet company that delivers digital content and internet communications services to users across the globe. The company’s search engine has faced fierce competition from Google Inc search, and is now on the track of making a comeback. The company is now the default search engine of Firefox browser. Funds with the highest in portfolio holding of the company were D E Shaw with 19.57 million shares, followed by Jat Capital Management with 8.85 million shares. (You can see complete list of hedge funds which hold positions on Yahoo! Inc. (NASDAQ:YHOO) at the end of third quarter.)
CF Industries Holdings, Inc. (NYSE:CF) was second on the list with $278.16 million worth of investment. CF Industries Holdings, Inc. (NYSE:CF) is a manufacturer and supplier of nitrogen fertilizers for both agricultural and industrial use. The company has several large-scale nitrogen complexes and a robust distribution system. CF Industries Holdings, Inc. (NYSE:CF) reported $2.90 in earnings per share for the third quarter of 2014. This was however short of consensus estimate of $3.47. The total revenue for the quarter was $921.40 million.
Third on the list of investments of Passport Capital, LLC, was Vipshop Holdings Ltd – ADR (NYSE:VIPS) with $185.53 million. Vipshop Holdings Ltd – ADR (NYSE:VIPS) is an online retailer of branded products, operating through flash sales where specific products are sold in limited quantities for a limited period of time. JPMorgan Chase & Co. recently raised the price target of the stock to $26 from $25 and has reiterated an “overweight” rating on the stock.
This article has been written by Victor Ochieng.
Related articles:
Top 20 Medical Schools in the US – 2014 Rankings
4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef
